Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for SWTX

Stock Name	SpringWorks Therapeutics Inc
Ticker	SWTX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US85205L1070

Show aggregate SWTX holdings

News associated with SWTX

Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in SpringWorks Therapeutics (NASDAQ:SWTX): Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 10,846 shares of the company’s stock, valued at approximately $479,000. Other institutional investors have also recently modified their holdings of the […] - 2025-08-04 05:14:49
Cwm LLC Acquires 1,923 Shares of SpringWorks Therapeutics (NASDAQ:SWTX): Cwm LLC boosted its holdings in SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) by 832.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,154 shares of the company’s stock after purchasing an additional 1,923 shares during the quarter. Cwm LLC’s holdings in […] - 2025-08-01 05:01:05
Envestnet Asset Management Inc. Sells 7,489 Shares of SpringWorks Therapeutics (NASDAQ:SWTX): Envestnet Asset Management Inc. cut its stake in SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) by 6.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 114,274 shares of the company’s stock after selling 7,489 shares during the period. Envestnet Asset Management Inc.’s […] - 2025-07-25 04:42:59
Victory Capital Management Inc. Cuts Stock Position in SpringWorks Therapeutics (NASDAQ:SWTX): Victory Capital Management Inc. lowered its stake in SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) by 29.6% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 432,951 shares of the company’s stock after selling 181,972 shares during the quarter. Victory Capital Management Inc.’s holdings in SpringWorks Therapeutics were worth $19,106,000 as of its most recent […] - 2025-07-23 05:12:55
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Sold by Principal Financial Group Inc.: Principal Financial Group Inc. lowered its position in SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) by 3.6% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,064,109 shares of the company’s stock after selling 39,749 shares during the period. Principal Financial […] - 2025-07-07 05:54:49
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Sold by Exchange Traded Concepts LLC: Exchange Traded Concepts LLC decreased its stake in shares of SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) by 45.7% in the 1st quarter, HoldingsChannel.com reports. The firm owned 2,556 shares of the company’s stock after selling 2,153 shares during the quarter. Exchange Traded Concepts LLC’s holdings in SpringWorks Therapeutics were worth $113,000 at the end of […] - 2025-06-25 05:28:58
SpringWorks Therapeutics (NASDAQ:SWTX) Receives $52.57 Consensus Target Price from Brokerages: SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) has earned a consensus recommendation of “Hold” from the eight research firms that are currently covering the company, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price target among brokers […] - 2025-06-20 02:20:17
State of Wyoming Boosts Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): State of Wyoming grew its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 39.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,530 shares of the company’s stock after purchasing an additional 433 shares during the quarter. State of Wyoming’s […] - 2025-05-29 04:47:00
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Average Recommendation of “Hold” from Brokerages: Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) have earned a consensus rating of “Hold” from the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average […] - 2025-05-23 04:22:52
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Bank of America Corp DE: Bank of America Corp DE reduced its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 51.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 416,888 shares of the company’s stock after selling 444,322 shares during the quarter. Bank of America Corp DE’s holdings in SpringWorks Therapeutics were worth $15,062,000 at the end […] - 2025-05-22 04:40:51
SpringWorks Therapeutics (NASDAQ:SWTX) Receives Neutral Rating from Guggenheim: SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report)‘s stock had its “neutral” rating restated by equities research analysts at Guggenheim in a research note issued to investors on Monday,Benzinga reports. They presently have a $47.00 price target on the stock. Guggenheim’s price target points to a potential upside of 1.69% from the company’s current price. A […] - 2025-05-14 02:36:44
Northern Trust Corp Acquires 52,908 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Northern Trust Corp grew its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 8.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 655,678 shares of the company’s stock after purchasing an additional 52,908 shares during the period. Northern Trust […] - 2025-05-13 05:31:21
Dimensional Fund Advisors LP Lowers Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Dimensional Fund Advisors LP reduced its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 1.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 717,714 shares of the company’s stock after selling 7,403 shares during the period. Dimensional Fund Advisors LP’s holdings in SpringWorks Therapeutics were worth $25,931,000 as […] - 2025-05-07 05:24:51
SpringWorks Therapeutics (NASDAQ:SWTX) Receives Hold Rating from TD Cowen: SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report)‘s stock had its “hold” rating restated by analysts at TD Cowen in a report released on Tuesday, Marketbeat Ratings reports. They presently have a $47.00 price objective on the stock, down from their previous price objective of $66.00. TD Cowen’s price target would suggest a potential upside of […] - 2025-05-01 04:48:58
SpringWorks Therapeutics (NASDAQ:SWTX) Lowered to “Hold” Rating by Evercore ISI: Evercore ISI lowered shares of SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) from a strong-buy rating to a hold rating in a report released on Monday,Zacks.com reports. A number of other research firms have also commented on SWTX. HC Wainwright restated a “buy” rating and issued a $74.00 price target on shares of SpringWorks Therapeutics in […] - 2025-05-01 02:37:02
Pre-Market Most Active for Apr 28, 2025 : TSLL, PFE, BBAI, INTC, NVDA, TSLA, SWTX, TQQQ, AMPY, SCHW, ABBV, NIO: The NASDAQ 100 Pre-Market Indicator is down -14.2 to 19,418.36. The total Pre-Market volume is currently 170,511,986 shares traded.The following are the most active stocks for the pre-market session: Direxion Daily TSLA Bull 2X Shares (TSLL) is +0.27 at $10.72, with 25,789,199 s - 2025-04-28 09:28:55
Envestnet Asset Management Inc. Grows Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Envestnet Asset Management Inc. raised its position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 1.3% in the fourth quarter, Holdings Channel reports. The fund owned 121,763 shares of the company’s stock after buying an additional 1,507 shares during the period. Envestnet Asset Management Inc.’s holdings in SpringWorks Therapeutics were worth $4,399,000 as of […] - 2025-04-24 04:26:48
Russell Investments Group Ltd. Cuts Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Russell Investments Group Ltd. lowered its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 19.4% in the 4th quarter, HoldingsChannel reports. The firm owned 112,942 shares of the company’s stock after selling 27,251 shares during the quarter. Russell Investments Group Ltd.’s holdings in SpringWorks Therapeutics were worth $4,081,000 as of its most recent […] - 2025-04-16 05:39:00
Norges Bank Invests $6.74 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Norges Bank bought a new stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 186,503 shares of the company’s stock, valued at approximately $6,738,000. Norges Bank owned 0.25% of SpringWorks Therapeutics as […] - 2025-04-09 04:53:04
Corebridge Financial Inc. Sells 2,579 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Corebridge Financial Inc. reduced its position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 7.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,178 shares of the company’s stock after selling 2,579 shares during the quarter. Corebridge Financial Inc.’s holdings in SpringWorks Therapeutics […] - 2025-04-04 04:37:00
Teacher Retirement System of Texas Increases Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Teacher Retirement System of Texas increased its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 26.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,609 shares of the company’s stock after buying an additional 3,674 shares during the period. Teacher Retirement […] - 2025-03-31 04:28:57
Cibc World Markets Corp Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Cibc World Markets Corp acquired a new position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 6,433 shares of the company’s stock, valued at approximately $232,000. Other large investors also recently […] - 2025-03-27 05:54:53
Swiss National Bank Acquires 8,000 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Swiss National Bank grew its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 7.4% during the fourth quarter, Holdings Channel reports. The firm owned 116,800 shares of the company’s stock after purchasing an additional 8,000 shares during the period. Swiss National Bank’s holdings in SpringWorks Therapeutics were worth $4,220,000 as of […] - 2025-03-26 05:42:52
M&T Bank Corp Grows Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): M&T Bank Corp lifted its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 16.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,155 shares of the company’s stock after purchasing an additional 2,774 shares during the period. […] - 2025-03-13 06:35:36
Assetmark Inc. Acquires 2,196 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Assetmark Inc. grew its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 4.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 48,216 shares of the company’s stock after acquiring an additional 2,196 shares during the quarter. Assetmark Inc.’s holdings in […] - 2025-03-11 06:20:55
Oppenheimer Asset Management Inc. Cuts Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX): Oppenheimer Asset Management Inc. lessened its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 6.2% in the fourth quarter, HoldingsChannel reports. The fund owned 12,559 shares of the company’s stock after selling 837 shares during the period. Oppenheimer Asset Management Inc.’s holdings in SpringWorks Therapeutics were worth $454,000 at the end of the […] - 2025-03-06 09:03:36
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Bought by State of New Jersey Common Pension Fund D: State of New Jersey Common Pension Fund D raised its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 19.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 55,343 shares of the company’s stock after buying an additional 8,954 shares during the period. State of New Jersey Common Pension […] - 2025-02-24 07:16:49
Analysts Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) PT at $70.83: Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) have received a consensus recommendation of “Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued a report on the stock […] - 2025-02-19 05:55:37
Contrasting SpringWorks Therapeutics (NASDAQ:SWTX) and Innate Pharma (OTCMKTS:IPHYF): SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) and Innate Pharma (OTCMKTS:IPHYF – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership. Profitability This table compares SpringWorks Therapeutics and Innate […] - 2025-02-13 06:46:56
Investors Purchase Large Volume of Call Options on SpringWorks Therapeutics (NASDAQ:SWTX): SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) was the recipient of some unusual options trading activity on Monday. Stock investors purchased 5,756 call options on the stock. This represents an increase of 721% compared to the average volume of 701 call options. Analyst Ratings Changes A number of analysts have commented on SWTX shares. […] - 2025-02-12 04:15:00

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) SWTX holdings

Date	Number of SWTX Shares Held	Base Market Value of SWTX Shares	Local Market Value of SWTX Shares	Change in SWTX Shares Held	Change in SWTX Base Value	Current Price per SWTX Share Held	Previous Price per SWTX Share Held

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SWTX by Blackrock for IE00BDZVHG35

Show aggregate share trades of SWTX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-06-11 BUY 250 46.750* 42.92
2025-06-10 BUY 250 46.740* 42.90
2025-06-04 SELL -125 46.710* 42.79 Profit of 5,348 on sale
2025-04-23 BUY 125 41.210* 41.89
2025-04-10 SELL -992 34.430* 42.28 Profit of 41,946 on sale
2025-04-08 SELL -124 35.710* 42.40 Profit of 5,258 on sale
2025-04-07 SELL -124 36.990* 42.46 Profit of 5,265 on sale
2025-04-04 SELL -625 39.090* 42.50 Profit of 26,560 on sale
2025-04-01 BUY 1,092 41.880* 42.46
2025-03-31 SELL -369 44.130* 42.44 Profit of 15,661 on sale
2025-03-21 BUY 1,867 49.890* 42.07
2025-03-14 SELL -1,872 51.140* 41.56 Profit of 77,809 on sale
2025-03-07 SELL -232 49.550* 41.02 Profit of 9,517 on sale
2025-03-04 SELL -116 51.380* 40.61 Profit of 4,711 on sale
2025-02-25 BUY 232 54.030* 39.61
2025-02-19 SELL -116 55.730* 38.50 Profit of 4,466 on sale
2025-02-13 BUY 348 58.590* 37.26
2025-02-12 BUY 116 59.280* 36.89
2025-02-11 BUY 464 55.130* 36.58
2025-01-17 BUY 468 34.630* 36.04
2025-01-16 BUY 468 35.590* 36.05
2025-01-10 SELL -232 43.000* 36.00 Profit of 8,352 on sale
2025-01-08 SELL -468 40.490* 35.74 Profit of 16,728 on sale
2024-12-30 SELL -3,962 36.340* 35.72 Profit of 141,505 on sale
2024-11-18 SELL -1,905 34.560* 30.89 Profit of 58,850 on sale
2024-11-08 SELL -127 33.990* 30.51 Profit of 3,875 on sale
2024-10-21 SELL -128 30.490* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-06-11	BUY	250	46.750*	42.92
2025-06-10	BUY	250	46.740*	42.90
2025-06-04	SELL	-125	46.710*	42.79 Profit of 5,348 on sale
2025-04-23	BUY	125	41.210*	41.89
2025-04-10	SELL	-992	34.430*	42.28 Profit of 41,946 on sale
2025-04-08	SELL	-124	35.710*	42.40 Profit of 5,258 on sale
2025-04-07	SELL	-124	36.990*	42.46 Profit of 5,265 on sale
2025-04-04	SELL	-625	39.090*	42.50 Profit of 26,560 on sale
2025-04-01	BUY	1,092	41.880*	42.46
2025-03-31	SELL	-369	44.130*	42.44 Profit of 15,661 on sale
2025-03-21	BUY	1,867	49.890*	42.07
2025-03-14	SELL	-1,872	51.140*	41.56 Profit of 77,809 on sale
2025-03-07	SELL	-232	49.550*	41.02 Profit of 9,517 on sale
2025-03-04	SELL	-116	51.380*	40.61 Profit of 4,711 on sale
2025-02-25	BUY	232	54.030*	39.61
2025-02-19	SELL	-116	55.730*	38.50 Profit of 4,466 on sale
2025-02-13	BUY	348	58.590*	37.26
2025-02-12	BUY	116	59.280*	36.89
2025-02-11	BUY	464	55.130*	36.58
2025-01-17	BUY	468	34.630*	36.04
2025-01-16	BUY	468	35.590*	36.05
2025-01-10	SELL	-232	43.000*	36.00 Profit of 8,352 on sale
2025-01-08	SELL	-468	40.490*	35.74 Profit of 16,728 on sale
2024-12-30	SELL	-3,962	36.340*	35.72 Profit of 141,505 on sale
2024-11-18	SELL	-1,905	34.560*	30.89 Profit of 58,850 on sale
2024-11-08	SELL	-127	33.990*	30.51 Profit of 3,875 on sale
2024-10-21	SELL	-128	30.490*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SWTX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-06-30	154,185	0	1,245,538	12.4%
2025-06-27	227,057	0	2,033,952	11.2%
2025-06-26	183,567	0	417,018	44.0%
2025-06-25	119,324	0	267,201	44.7%
2025-06-24	129,386	1,100	408,343	31.7%
2025-06-23	398,261	0	908,604	43.8%
2025-06-20	620,878	0	2,651,316	23.4%
2025-06-18	398,589	0	939,820	42.4%
2025-06-17	150,262	0	270,094	55.6%
2025-06-16	289,551	0	680,566	42.5%
2025-06-13	185,913	0	606,144	30.7%
2025-06-12	188,931	0	446,310	42.3%
2025-06-11	226,823	24	614,826	36.9%
2025-06-10	101,517	0	256,789	39.5%
2025-06-09	174,728	0	417,499	41.9%
2025-06-06	104,477	0	209,917	49.8%
2025-06-05	435,787	0	741,695	58.8%
2025-06-04	475,042	0	729,516	65.1%
2025-06-03	100,101	0	459,035	21.8%
2025-06-02	233,610	0	973,001	24.0%
2025-05-30	354,163	0	501,108	70.7%
2025-05-29	126,749	0	386,530	32.8%
2025-05-28	244,025	0	1,100,688	22.2%
2025-05-27	196,295	1,050	529,911	37.0%
2025-05-23	383,602	0	1,527,640	25.1%
2025-05-22	215,891	0	379,804	56.8%
2025-05-21	446,679	83	957,267	46.7%
2025-05-20	129,664	0	273,935	47.3%
2025-05-19	207,147	0	490,871	42.2%
2025-05-16	816,779	6,698	2,638,855	31.0%
2025-05-15	605,865	5,472	1,839,103	32.9%
2025-05-14	734,421	1,541	1,073,165	68.4%
2025-05-13	366,496	0	816,870	44.9%
2025-05-12	1,562,850	2,757	3,333,856	46.9%
2025-05-09	384,358	0	617,141	62.3%
2025-05-08	591,924	0	1,228,237	48.2%
2025-05-07	339,402	0	1,528,907	22.2%
2025-05-06	643,691	0	1,340,706	48.0%
2025-05-05	236,172	20,433	640,154	36.9%
2025-05-02	337,077	1,255	1,916,429	17.6%
2025-05-01	279,230	140	1,993,786	14.0%
2025-04-30	795,672	5,963	3,154,978	25.2%
2025-04-29	1,259,426	382,408	6,260,855	20.1%
2025-04-28	6,212,824	15,327	26,455,518	23.5%
2025-04-25	1,540,057	4,691	3,643,929	42.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE